BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9563444)

  • 1. Nm23 gene expression in gastric carcinoma: an immunohistochemical study.
    Yeung P; Lee CS; Marr P; Sarris M; Fenton-Lee D
    Aust N Z J Surg; 1998 Mar; 68(3):180-2. PubMed ID: 9563444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
    Sarris M; Lee CS
    Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of nm23 protein expression in human gastric carcinomas.
    Ura H; Denno R; Hirata K
    Surg Today; 1996; 26(12):957-65. PubMed ID: 9017955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.
    Müller W; Schneiders A; Hommel G; Gabbert HE
    Cancer; 1998 Dec; 83(12):2481-7. PubMed ID: 9874452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma.
    Yoo CH; Noh SH; Kim H; Lee HY; Min JS
    J Surg Oncol; 1999 May; 71(1):22-8. PubMed ID: 10362087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53 and NDP-K/nm23 in gastric carcinomas--association with metastasis and clinicopathologic parameters.
    Kim KM; Lee A; Chae HS; Shim SI
    J Korean Med Sci; 1995 Dec; 10(6):406-13. PubMed ID: 8924224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of nm23 gene product, nucleotide diphosphate kinase, in pancreatic neoplasms.
    Ohshio G; Imamura T; Okada N; Suwa H; Yamaki K; Imamura M; Ogasahara K; Tsukayama C; Yamabe H
    Int J Pancreatol; 1997 Aug; 22(1):59-66. PubMed ID: 9387026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
    Cheah PY; Cao X; Eu KW; Seow-Choen F
    Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. nm23-H1 protein immunoreactivity in laryngeal carcinoma.
    Lee CS; Redshaw A; Boag G
    Cancer; 1996 Jun; 77(11):2246-50. PubMed ID: 8635091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
    Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
    Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFP-producing carcinoma.
    Kumar Dhar D; Kubota H; Tabara H; Kotoh T; Monden N; Igarashi M; Kohno H; Nagasue N
    Oncology; 1999; 56(2):122-8. PubMed ID: 9949298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas.
    Nakayama H; Yasui W; Yokozaki H; Tahara E
    Jpn J Cancer Res; 1993 Feb; 84(2):184-90. PubMed ID: 8096503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression and significance of NM23 suppressor protein in primary gastric adenocarcinoma.
    Radović S; Dorić M; Hukić A; Babić M; Kuskunović S; Spahović N
    Bosn J Basic Med Sci; 2013 May; 13(2):72-7. PubMed ID: 23725501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of nm23 gene product in human gallbladder carcinomas.
    Fujii K; Yasui W; Shimamoto F; Yokozaki H; Nakayama H; Kajiyama G; Tahara E
    Virchows Arch; 1995; 426(4):355-9. PubMed ID: 7599787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
    Tannapfel A; Köckerling F; Katalinic A; Wittekind C
    Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer.
    Yoshida H; Kijima H; Terasaki Y; Suto A; Takeshita T; Omiya H; Shimojima K; Shimbori M; Sato T; Sato S; Onoda N; Yamazaki H; Tamaoki N; Ueyama Y; Nakamura M
    Int J Oncol; 1998 Dec; 13(6):1141-6. PubMed ID: 9824622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Anti-metastatic' nm23 gene product expression in keratoacanthoma and squamous cell carcinoma.
    Stephenson TJ; Royds JA; Bleehen SS; Silcocks PB; Rees RC
    Dermatology; 1993; 187(2):95-9. PubMed ID: 8358113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of NM23 and tenascin in invasive ductal carcinomas of the breast.
    Kaya H; Hücümenoğlu S; Bozkurt SU; Ekicioğlu G; Kotiloğlu E
    Eur J Gynaecol Oncol; 2002; 23(3):261-3. PubMed ID: 12094967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implication of nm23-H1 expression in colorectal carcinomas.
    Dursun A; Akyürek N; Günel N; Yamaç D
    Pathology; 2002 Oct; 34(5):427-32. PubMed ID: 12408341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical analysis of c-erB-2 and nm23 expression in early gastric carcinoma].
    Aoyagi K; Koufuji K; Kodama I; Ohta J; Takamiya H; Mizutani K; Takeda J; Shirouzu K
    Nihon Shokakibyo Gakkai Zasshi; 1996 Sep; 93(9):613-9. PubMed ID: 8965386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.